Transformant clones are selected based on drug resistance determined by the selection cassette used in the transformation construct. The level of replacement by the transgene construct is not determined unless complete replacement is requested. Complete replacement is monitored by PCR analysis across the insertion site, using primer sequences provided by the client. Note that complete replacement is dependent on a number of factors, including the target site and the transforming vector used, and may not be possible for some constructs.